| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jane Chung | Chief Executive Officer | 2026-03-04 | 282 | $21.31 | $6.01kSell |
| David Pauling | Chief Admin. Ofcr. GC | 2026-03-04 | 277 | $21.31 | $5.90kSell |
| Hanspeter Gerber | CHIEF SCIENTIFIC OFFICER | 2026-03-02 | 1,170 | $20.55 | $24.04kSell |
| David Pauling | Chief Admin. Ofcr. GC | 2026-03-02 | 970 | $20.55 | $19.93kSell |
| Jane Chung | Chief Executive Officer | 2026-03-02 | 2,779 | $20.55 | $57.11kSell |
| Hanspeter Gerber | CHIEF SCIENTIFIC OFFICER | 2026-03-01 | 463 | $20.47 | $9.48kSell |
| Jane Chung | Chief Executive Officer | 2026-03-01 | 1,271 | $20.47 | $26.02kSell |
| David Pauling | Chief Admin. Ofcr. GC | 2026-03-01 | 551 | $20.47 | $11.28kSell |
| Jane Chung | Chief Executive Officer | 2025-12-12 | 894 | $8.02 | $7.17kSell |
| Hanspeter Gerber | CHIEF SCIENTIFIC OFFICER | 2025-10-15 | 17,000 | $0.80 | $13.60kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Merck Co Inc | 16.43% | 2,723,509 | $42.16M | Insider |
| Skyline Venture Partners V LP | 11.82% | 1,960,053 | $30.34M | Insider |
| Daniel Janney | 11.73% | 1,944,901 | $30.11M | Insider |
| Alta Partners VIII LP | 11.73% | 1,944,901 | $30.11M | Insider |
| Svlsf V LLC | 11.00% | 1,824,542 | $28.24M | Insider |
| Michael Jay Ross | 11.00% | 1,824,542 | $28.24M | Insider |
| Celgene Corp | 10.41% | 1,726,197 | $26.72M | Insider |
| William J. Newell | 2.82% | 466,878 | $7.23M | Insider |
| Edward C. Albini | 0.97% | 160,805 | $2.49M | Insider |
| Linda A. Fitzpatrick | 0.91% | 150,893 | $2.34M | Insider |